Crohn鈥檚 Disease Treatment - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240753

Publication Date:

September 5, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Crohn's disease is听a type of inflammatory bowel disease (IBD). It causes swelling of the tissues (inflammation) in your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition.
The global market for Crohn鈥檚 Disease Treatment was estimated to be worth US$ 6157 million in 2023 and is forecast to a readjusted size of US$ 8667.7 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
The ulcerative colitis disease treatment market is driven by the increasing prevalence of ulcerative colitis and the growing demand for effective therapies to manage the condition. Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the colon and rectum. The rise in the incidence of ulcerative colitis and the impact of lifestyle factors contribute to the growing burden of the disease. The market is propelled by advancements in medical research, leading to the development of new drugs and biologics that target the underlying inflammatory pathways. However, the market also faces challenges, including the complexity of managing the disease and the need for personalized treatment approaches. Additionally, the high cost of biologics and the potential for adverse effects pose obstacles for both patients and healthcare systems. To succeed, companies must focus on research and development to provide innovative treatment options, collaborate with healthcare providers to develop comprehensive disease management programs, and address the challenges to meet the increasing demand for ulcerative colitis treatments.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Crohn鈥檚 Disease Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Crohn鈥檚 Disease Treatment by region & country, by Type, and by Application.
The Crohn鈥檚 Disease Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn鈥檚 Disease Treatment.
麻豆原创 Segmentation
By Company
Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Segment by Type:
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others
Segment by Application
Hospitals
Specialty Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Crohn鈥檚 Disease Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Crohn鈥檚 Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Crohn鈥檚 Disease Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Crohn鈥檚 Disease Treatment Product Introduction
1.2 Global Crohn鈥檚 Disease Treatment 麻豆原创 Size Forecast
1.3 Crohn鈥檚 Disease Treatment 麻豆原创 Trends & Drivers
1.3.1 Crohn鈥檚 Disease Treatment Industry Trends
1.3.2 Crohn鈥檚 Disease Treatment 麻豆原创 Drivers & Opportunity
1.3.3 Crohn鈥檚 Disease Treatment 麻豆原创 Challenges
1.3.4 Crohn鈥檚 Disease Treatment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Crohn鈥檚 Disease Treatment Players Revenue Ranking (2023)
2.2 Global Crohn鈥檚 Disease Treatment Revenue by Company (2019-2024)
2.3 Key Companies Crohn鈥檚 Disease Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Crohn鈥檚 Disease Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Crohn鈥檚 Disease Treatment
2.6 Crohn鈥檚 Disease Treatment 麻豆原创 Competitive Analysis
2.6.1 Crohn鈥檚 Disease Treatment 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Crohn鈥檚 Disease Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn鈥檚 Disease Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibiotics
3.1.2 Amino Salicylates
3.1.3 Corticosteroids
3.1.4 Immunomodulators
3.1.5 Others
3.2 Global Crohn鈥檚 Disease Treatment Sales Value by Type
3.2.1 Global Crohn鈥檚 Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Crohn鈥檚 Disease Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Crohn鈥檚 Disease Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Other
4.2 Global Crohn鈥檚 Disease Treatment Sales Value by Application
4.2.1 Global Crohn鈥檚 Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Crohn鈥檚 Disease Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Crohn鈥檚 Disease Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Crohn鈥檚 Disease Treatment Sales Value by Region
5.1.1 Global Crohn鈥檚 Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Crohn鈥檚 Disease Treatment Sales Value by Region (2019-2024)
5.1.3 Global Crohn鈥檚 Disease Treatment Sales Value by Region (2025-2030)
5.1.4 Global Crohn鈥檚 Disease Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
5.2.2 North America Crohn鈥檚 Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
5.3.2 Europe Crohn鈥檚 Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Crohn鈥檚 Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
5.5.2 South America Crohn鈥檚 Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Crohn鈥檚 Disease Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Crohn鈥檚 Disease Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Crohn鈥檚 Disease Treatment Sales Value
6.3 United States
6.3.1 United States Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.3.2 United States Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.4.2 Europe Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.5.2 China Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.6.2 Japan Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.7.2 South Korea Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Crohn鈥檚 Disease Treatment Sales Value, 2019-2030
6.9.2 India Crohn鈥檚 Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Crohn鈥檚 Disease Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Profile
7.1.2 Abbvie Inc. Main Business
7.1.3 Abbvie Inc. Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.1.4 Abbvie Inc. Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Abbvie Inc. Recent Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Profile
7.2.2 Bristol Myers Squibb Main Business
7.2.3 Bristol Myers Squibb Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.2.4 Bristol Myers Squibb Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bristol Myers Squibb Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.3.4 Roche Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.4.4 Johnson & Johnson Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Recent Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Profile
7.5.2 Pfizer Inc. Main Business
7.5.3 Pfizer Inc. Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.5.4 Pfizer Inc. Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer Inc. Recent Developments
7.6 Prometheus Laboratories Inc. (Nestle)
7.6.1 Prometheus Laboratories Inc. (Nestle) Profile
7.6.2 Prometheus Laboratories Inc. (Nestle) Main Business
7.6.3 Prometheus Laboratories Inc. (Nestle) Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.6.4 Prometheus Laboratories Inc. (Nestle) Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
7.7 Bausch Health
7.7.1 Bausch Health Profile
7.7.2 Bausch Health Main Business
7.7.3 Bausch Health Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.7.4 Bausch Health Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Bausch Health Recent Developments
7.8 Takeda Pharmaceutical Ltd
7.8.1 Takeda Pharmaceutical Ltd Profile
7.8.2 Takeda Pharmaceutical Ltd Main Business
7.8.3 Takeda Pharmaceutical Ltd Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.8.4 Takeda Pharmaceutical Ltd Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Takeda Pharmaceutical Ltd Recent Developments
7.9 Biogen
7.9.1 Biogen Profile
7.9.2 Biogen Main Business
7.9.3 Biogen Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.9.4 Biogen Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Biogen Recent Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Profile
7.10.2 AstraZeneca Main Business
7.10.3 AstraZeneca Crohn鈥檚 Disease Treatment Products, Services and Solutions
7.10.4 AstraZeneca Crohn鈥檚 Disease Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 AstraZeneca Recent Developments
8 Industry Chain Analysis
8.1 Crohn鈥檚 Disease Treatment Industrial Chain
8.2 Crohn鈥檚 Disease Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Crohn鈥檚 Disease Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Crohn鈥檚 Disease Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.